DE2105560A1 - Purinribonucleosid-Derivate und Verfahren zur Herstellung derselben - Google Patents

Purinribonucleosid-Derivate und Verfahren zur Herstellung derselben

Info

Publication number
DE2105560A1
DE2105560A1 DE19712105560 DE2105560A DE2105560A1 DE 2105560 A1 DE2105560 A1 DE 2105560A1 DE 19712105560 DE19712105560 DE 19712105560 DE 2105560 A DE2105560 A DE 2105560A DE 2105560 A1 DE2105560 A1 DE 2105560A1
Authority
DE
Germany
Prior art keywords
general formula
processes
purine
making
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712105560
Other languages
German (de)
English (en)
Inventor
Wolfgang Dr.rer.nat 6805 Heddesheim;Fauland Erich Dr.techn.;Thiel Max Dr.rer.nat; Dietmann Karl Dr.med. Juhran Wolfgang Dr.med.vet; 6800 Mannheim Kampe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19712105560 priority Critical patent/DE2105560A1/de
Priority to GB490872A priority patent/GB1322301A/en
Priority to CH158372A priority patent/CH565815A5/xx
Priority to AT89472A priority patent/AT312816B/de
Publication of DE2105560A1 publication Critical patent/DE2105560A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712105560 1971-02-06 1971-02-06 Purinribonucleosid-Derivate und Verfahren zur Herstellung derselben Pending DE2105560A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19712105560 DE2105560A1 (de) 1971-02-06 1971-02-06 Purinribonucleosid-Derivate und Verfahren zur Herstellung derselben
GB490872A GB1322301A (en) 1971-02-06 1972-02-02 Purine-ribonucleoside derivatives
CH158372A CH565815A5 (enExample) 1971-02-06 1972-02-03
AT89472A AT312816B (de) 1971-02-06 1972-02-04 Verfahren zur Herstellung neuer Purinribonucleosid-Derivate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712105560 DE2105560A1 (de) 1971-02-06 1971-02-06 Purinribonucleosid-Derivate und Verfahren zur Herstellung derselben

Publications (1)

Publication Number Publication Date
DE2105560A1 true DE2105560A1 (de) 1972-09-07

Family

ID=5797950

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712105560 Pending DE2105560A1 (de) 1971-02-06 1971-02-06 Purinribonucleosid-Derivate und Verfahren zur Herstellung derselben

Country Status (4)

Country Link
AT (1) AT312816B (enExample)
CH (1) CH565815A5 (enExample)
DE (1) DE2105560A1 (enExample)
GB (1) GB1322301A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2186470A1 (en) * 1972-05-30 1974-01-11 Henning Berlin Gmbh Purine nucleoside nitrates - for treating cardiac insufficiency
US4115641A (en) * 1976-08-06 1978-09-19 Hoffmann-La Roche Inc. Ribofuranosyl-imidazole derivatives
FR2684997A1 (fr) * 1991-12-12 1993-06-18 Centre Nat Rech Scient Derives de la 9-(beta-d-xylofurannosyl) adenine et de la 1-(beta-d-xylofurannosyl) cytosine, leur preparation et leur application en therapeutique.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2186470A1 (en) * 1972-05-30 1974-01-11 Henning Berlin Gmbh Purine nucleoside nitrates - for treating cardiac insufficiency
US4115641A (en) * 1976-08-06 1978-09-19 Hoffmann-La Roche Inc. Ribofuranosyl-imidazole derivatives
FR2684997A1 (fr) * 1991-12-12 1993-06-18 Centre Nat Rech Scient Derives de la 9-(beta-d-xylofurannosyl) adenine et de la 1-(beta-d-xylofurannosyl) cytosine, leur preparation et leur application en therapeutique.
WO1993012128A1 (fr) * 1991-12-12 1993-06-24 Centre National De La Recherche Scientifique (Cnrs) DERIVES DE LA 9-(β-D-XYLOFURANNOSYL) ADENINE ET DE LA 1-(β-D-XYLOFURANNOSYL)CYTOSINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Also Published As

Publication number Publication date
CH565815A5 (enExample) 1975-08-29
AT312816B (de) 1974-01-25
GB1322301A (en) 1973-07-04

Similar Documents

Publication Publication Date Title
DE2756216A1 (de) Phenylalkylhydroxamsaeuren, ihre herstellung und verwendung in arzneimitteln
DE2513842A1 (de) 3-amino-dihydrothiophenon-2-derivate und ihr herstellungsverfahren
DE2204574A1 (de) Verfahren zur herstellung von 3-aminobenzo-1,2,4-triazin-di-n-oxiden (1,4)
DE1948943C2 (de) Arzneimittel, enthaltend D-α-Sulfobenzylpenicillin
DE2721987C2 (de) p-Acetamidophenyldiäthylaminoacetat, dessen pharmakologisch unbedenkliche Additionssalze, Verfahren zu deren Herstellung und Arzneimittel mit diesen Verbindungen als Wirkstoff
DE1770944A1 (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
DE2726793A1 (de) 2-imino-3-aminothiazolidine
DE2738498C3 (de) H2-Chloräthyl)-l-nitroso-3-(2-acetamido-2desoxy- ß -D-glucopyranosyl)- harnstoffe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH629806A5 (en) Process for the preparation of substituted purines
EP0253293B1 (de) Neue Guanidiniumasparaginate
DE1926557A1 (de) Cholecystographische Roentgenkontrastmittel
DE2338350A1 (de) Beta-(3,4-dialkanoyloxyphenyl)-lalanin-ester
AT293361B (de) Verfahren zur Herstellung von neuen β-Aminoacrylophenonen und deren Salzen
DE2142385C3 (de) 1 -Adamanty1-4-(3"-nitrophenyl) -I^.S.e-tetrahydropyrimidin^-on, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
AT361942B (de) Verfahren zur herstellung von neuen 9-substi- tuierten purinen und ihren salzen
AT213899B (de) Verfahren zur Herstellung des neuen 3-(p-Amino-benzolsulfonamido)-6-oxy-pyridazins und seiner Salze
AT269141B (de) Verfahren zur Herstellung des neuen 2-Methoxy-4-(N<4>-glutarylsulfanilamido)-chinazolins und dessen pharmazeutisch verträglicher Metallsalze
AT220288B (de) Verfahren zur Herstellung von neuen therapeutisch wirksamen Estern des Erythromycins
AT337709B (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT367054B (de) Verfahren zur herstellung von mono-alkenyl-dialkylxanthinen
AT286495B (de) Verfahren zur Herstellung von neuen Estern des α-Amino-benzylpenicillins
DE2060189A1 (de) Neue Adenosin-Derivate und Verfahren zu deren Herstellung
DE2211419A1 (de) Penicilloinsaurederivate
DE2404308C3 (de) Thieno bzw. Furo [3,2-c] pyridiniumderivate sowie deren 43,6,7-Tetrahydroderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
AT353281B (de) Verfahren zur herstellung von neuen 4-(beta- -ureidoaethyl)-benzolsulfonylharnstoffen und deren salzen

Legal Events

Date Code Title Description
OD Request for examination
OHW Rejection